Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy.
Heerspink HJL, Jardine M, Kohan DE, Lafayette RA, Levin A, Liew A, Zhang H, Noronha I, Trimarchi H, Hou FF, Renfurm R, Gray T, Camargo M, Barratt J.
Heerspink HJL, et al. Among authors: gray t.
Kidney Int Rep. 2024 Oct 10;10(1):217-226. doi: 10.1016/j.ekir.2024.10.004. eCollection 2025 Jan.
Kidney Int Rep. 2024.
PMID: 39810771
Free PMC article.